United States

Managing risk as a life sciences company grows


In the biotech field, most people perceive risk as whether a drug will succeed or fail in a clinical study. But as biotech companies mature, the risks they need to manage grow in complexity, particularly as companies become increasingly reliant on a complex network of external relationships. Hear from RSM’s Life Sciences Senior Analyst Steve Kemler about the types of risks biotech companies face and how to manage them, as well as why biotech companies should develop a risk assessment framework.


Other episodes


Why life sciences companies should consider implementing an ERP system

Learn why life sciences companies should consider implementing an enterprise resource planning (ERP) system. Listen to the audiocast.


Subscribe to Life Sciences newsletter

How can we help you?

Contact us by phone 800.274.3978 or submit your questions, comments, or proposal requests.